心血管健康指标在患有癌症和没有癌症的个体之间有所不同
Ofer Kobo1,2, Dmitry Abramov3, Manuela Fiuza4
1Department of Cardiology Hillel Yaffe Medical Center Hadera Israel.
Journal of the American Heart Association
|December 1, 2023
概括
患有癌症的人心血管健康 (CVH) 评分较低,但身体活动和饮食等关键行为更好. 这些发现突出了差异,并为改善癌症患者CVH的策略提供了信息.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 癌症幸存者面临的心血管疾病的高率.
- 癌症患者与普通人群之间心血管健康 (CVH) 差异的数据有限.
研究的目的:
- 为了比较美国成年人与没有癌症史之间的CVH指标.
- 分析基于年龄,性别,种族,民族和社会经济地位等人口统计数据的CVH得分变化.
主要方法:
- 利用了来自国家健康和营养检查调查 (2015-2020) 的数据.
- 评估了美国心脏协会对CVH的生命必不可少的8项构造.
- 分析了4370名成年参与者的健康指标流行率和得分,其中9.4%的人有癌症史.
主要成果:
- 癌症患者的整体CVH得分明显较低 (67.1比69.1,P<0.001).
- 癌症患者在体力活动,饮食和睡眠行为方面表现更好.
- 这些行为改善在老年人,白人和社会经济地位较高的人群中更为明显.
结论:
- 在癌症患者和非癌症患者之间,CVH指标存在显著差异.
- 人口因素 (年龄,种族,种族,社会经济地位) 影响这些CVH差异.
- 研究结果为优化癌症患者心血管保健和解决健康差异提供了一个框架.
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
167
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
167
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
96
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
Assessment of the Cardiovascular System II: Inspection
265
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
265
Special considerations while measuring blood pressure
725
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
725


